title: Tri-city study of Ecstasy use problems: a latent class analysis.
abstract: This study used latent class analysis to examine distinctive subtypes of Ecstasy users based on 24 abuse and dependence symptoms underlying standard DSM-IV criteria. Data came from a three site, population-based, epidemiological study to examine diagnostic nosology for Ecstasy use. Subject inclusion criteria included lifetime Ecstasy use exceeding five times and once in the past year, with participants ranging in age between 16 and 47 years of age from St. Louis, Miami, U.S. and Sydney, Australia. A satisfactory model typified four latent classes representing clearly differentiated diagnostic clusters including: (1) a group of sub-threshold users endorsing few abuse and dependence symptoms (negatives), (2) a group of 'diagnostic orphans' who had characteristic features of dependence for a select group of symptoms (mild dependent), (3) a 'transitional group' mimicking the orphans with regard to their profile of dependence also but reporting some abuse symptoms (moderate dependent), and (4) a 'severe dependent' group with a distinct profile of abuse and dependence symptoms. A multinomial logistic regression model indicated that certain latent classes showed unique associations with external non-diagnostic markers. Controlling for demographic characteristics and lifetime quantity of Ecstasy pill use, criminal behavior and motivational cues for Ecstasy use were the most efficient predictors of cluster membership. This study reinforces the heuristic utility of DSM-IV criteria applied to Ecstasy but with a different collage of symptoms that produced four distinct classes of Ecstasy users.
authors.affiliation: LARS Research Institute, Inc., Las Vegas, NV 89135, USA.
authors.forename: Lawrence M
authors.initials: LM
authors.lastname: Scheier
authors.forename: Arbi
authors.initials: A
authors.lastname: Ben Abdallah
authors.forename: James A
authors.initials: JA
authors.lastname: Inciardi
authors.forename: Jan
authors.initials: J
authors.lastname: Copeland
authors.forename: Linda B
authors.initials: LB
authors.lastname: Cottler
mesh_terms: D000328:Adult; D019969:Amphetamine-Related Disorders / Q000453:epidemiology* / Q000523:psychology; D003863:Depression / Q000453:epidemiology / Q000523:psychology; D005190:Family; D005260:Female; D006213:Hallucinogens; D006801:Humans; D016015:Logistic Models; D008297:Male; D015233:Models, Statistical; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D011569:Psychiatric Status Rating Scales; D012067:Religion; D018570:Risk Assessment; D012944:Social Support; D012959:Socioeconomic Factors; D013315:Stress, Psychological / Q000453:epidemiology / Q000523:psychology; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000523:psychology; D055815:Young Adult
chemical_list: D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine